-+ 0.00%
-+ 0.00%
-+ 0.00%

Coeptis Therapeutics Shareholders Approve Proposed Merger With Z Squared

Benzinga·02/05/2026 21:02:41
Listen to the news

Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) ("Coeptis" or the "Company"), a next-gen technology and biopharmaceutical company, today announced that its shareholders have voted to approve the previously announced merger with Z Squared Inc.

The transaction was approved on January 30, 2026, by Coeptis' shareholders. In connection with the consummation of the business combination, Z Squared will become a wholly owned subsidiary of Coeptis. The transaction remains subject to satisfaction of the remaining conditions to closing.